Gilles Brisson

Gilles Brisson has extensive experience in the pharmaceutical and biotechnology sectors, currently serving as a Member and Chairman of the Supervisory Board at Innate Pharma since February 2007. Brisson is also a member of the Board of Directors at LFB (Laboratoire Fractionnement et des Biotechnologies) and a Member of the Supervisory Board at Ethypharm, both positions held since 2018 and 2019, respectively. Previous roles include Chairman of the Supervisory Board at Financière Verdi III (Ethypharm), Board member at Carso Group, President of the Supervisory Board at Mutabilis Holding, and Senior Vice President Europe at Sanofi-aventis and Aventis. Brisson's educational background includes studies at HEC Paris and prestigious secondary institutions in Paris.